![](/img/cover-not-exists.png)
Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
Ravelli, A, Brunner, HI, Ruperto, N, Quartier, P, Consolaro, A, Wulffraat, N, Lheritier, K, Gaillez, C, Martini, A, Lovell, DJVolume:
12
Year:
2014
Language:
english
Journal:
Pediatric Rheumatology
DOI:
10.1186/1546-0096-12-S1-P63
File:
PDF, 276 KB
english, 2014